• About
    • Our Mission
    • Threat of AMR
    • Access and Appropriate Use Principles
    • Our Investors
  • Team
  • Investments
    • How We Invest
    • Our Portfolio
    • Get On Our Radar
  • News
  • Connect
  • All
  • In the News
  • Press Releases
  • Media
November 1, 2024
Media

FP Analytics Synthesis Report: A World Without Antibiotics

Read More +
October 16, 2024
In the News

AMR Action Fund Expands Portfolio with Investment in TenNor Therapeutics

Read More +
September 24, 2024
In the News

Forbes: Smart Antibiotics Could Fight Infections While Sparing the Gut

Read More +
September 18, 2024
In the News

LA Times: Drug-Resistant Germs Will Kill Millions More People in Coming Decades, Researchers Warn

Read More +
September 12, 2024
In the News

Antifungal Developer F2G Announces New Financing Led by AMR Action Fund

Read More +
August 26, 2024
In the News

MSCI Sustainability Institute, IAAMR, and FAIRR Release Health and Wealth: The Investors' Guide to AMR, A Growing Global Health Crisis

Read More +
August 3, 2024
In the News

Forbes: Antimicrobial Resistance On The Rise Due To Wars In Ukraine And Gaza

Read More +
June 17, 2024
In the News

AMR Action Fund Expands Portfolio with Investment in Elion Therapeutics

Read More +
Previous page Next page
contact-bg-img

Connect With Us

Contact
footer_logo

Enabling
Breakthroughs in
Antimicrobials

Stay connected

Stay up-to-date on our work to bring 2 to 4 new antibiotics to patients by the end of the decade. When we have news, we will let you know.

  • About
  • Team
  • Latest
  • Threat of AMR
  • Connect
  • Investments
  • Japan Disclaimer
  • Privacy Policy